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Sir,
Dr Adami et al (2003) reported on the risk of cancer following
organ transplantation through a nationwide cohort study con-
ducted in Sweden. They reported a persistent, about four-fold
increased overall cancer risk and postulated that most of the risks
they observed might be attributable to the organ transplantation
and subsequent immunosuppressive therapy.
However, we identified an excess risk of cancer in a large cohort
of 831804 nontransplanted end-stage renal disease patients
receiving maintenance dialysis in the United States, Europe,
Australia and New Zealand (Maisonneuve et al, 1999). The
distribution of tumour types (excluding lip, nonmelanoma skin
cancer and post-transplant lymphomas) that was observed in these
nontransplanted patients resembled the pattern generally seen
after transplantation. Since, in both studies, the risk of cancer was
higher among younger patients, the fact that transplantation is
generally offered in younger patients could, in part, explain why
slightly higher risks are observed among the transplanted group.
Already in 1990, Pecqueux et al (1990) studied cancer incidence in
patients on chronic dialysis and in renal transplant recipients and
concluded that transplantation and consecutive immunosuppres-
sion does not appear to constitute an additional cancer risk for the
uraemic patient who is faced with either chronic dialysis or renal
transplantation.
For the dialysed patients and kidney recipients, we believe that
the underlying renal or urinary tract disease, the loss of renal
function, or the increased susceptibility to viral carcinogenesis
associated with an impaired immune system because of the
uraemic state is responsible for most of the increased risk of
cancer. The excess of renal parenchymal cancer observed is
consistent with causation through acquired renal cystic disease,
while the excess of urothelial cancers is consistent with the
carcinogenic effects of certain primary renal diseases (Stewart et al,
2003). We agree that post-transplant immunosuppressive therapy
could be responsible for the development of a large part of the
nonmelanoma skin cancers, for cancers of the lip, and for post-
transplant lymphomas.
Adami and co-workers also failed to identify a significant excess
of cervical cancer, in contrast with a previous report based on
similar data (Birkeland et al, 1995). Since some cervical cancers
could have well been recorded as uterus unspecified, it would have
been informative to get results for this category.
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